new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge bioinformatics software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one bioinformatics software provider empowering you from Sample to Insight.
We're pleased to announce that our newest clinical NGS variant interpretation and reporting solution...
Read about how researchers across the world are using QIAGEN Digital Insights solutions to accelerat...
Introducing a new login portal QIAGEN Digital Insights is introducing a new login URL to access H...
Need to expand your bioinformatics and curation expertise to harness the power of ‘omics...
The proGenomes2 project is a set of over 85,000 consistently annotated bacterial and archaeal genom...
QCI Interpret One is now available in Europe
QIAGEN Digital Insights Publication Roundup (Fall 2020)
HGMD, ANNOVAR, Genome Trax, and PGMD users now have a new, more robust login portal
Expand your bioinformatics capabilties with QIAGEN Discovery Bioinformatics Services
How to use proGenomes2 for taxonomic profiling in QIAGEN CLC Genomics Workbench
Targeted NGS panels and optimized analysis and interpretation bioinformatics software tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics software and services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
Join us at an event or attend a webinar to learn how our products, solutions and services are empowering customers around the world to unlock valuable molecular insights.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients